Bextra Lawyers

Winder & Haslam is representing Bextra users who suffered a heart attack or stroke. If you or a loved one has been injured as a result of Bextra, we encourage you to contact us for more information about your legal rights.

Bextra Warning

On December 23, 2004, the FDA urged doctors to limit prescribing Bextra. The FDA was concerned of recent evidence that the drug may increase the risk of heart attack and stroke. Bextra came under close scrutiny following the Vioxx recall.

Many physicians believe the problems that plagued Vioxx may also exist with Bextra. Both Bextra and Vioxx belong to a class of pharmaceuticals known as Cox-2 Inhibitors. If you or a loved one has been injured as a result of Bextra, we encourage you to learn more about the Bextra lawsuit.

Bextra Linked to Heart Attacks, Strokes

On November 10, 2004, a study conducted by the American Heart Association indicated a strong link between heart attacks and strokes. The study combined data from 5,930 patients participating in 12 separate trials. The results showed that patients given Bextra were at a 2.19 times greater risk of suffering a heart attack or stroke.

Pfizer disclosed on October 15 that high-risk heart patients taking Bextra were at an elevated risk of suffering significant cardiovascular problems. The manufacturer added a warning to this effect on the labeling for Bextra. Bextra now carries a black box warning, the most serious of warnings appearing on pharmaceuticals.

Stevens Johnson Syndrome

Bextra also is linked to a potentially fatal skin condition known as Stevens Johnson Syndrome. Symptoms of the disease include skin rash, blistering, fever, cough, and swelling.

Bextra and Your Health

If you are currently taking Bextra, you should meet with your physician to discuss alternatives. You should not stop using the medication unless your doctor instructs you to do so.

For more information about the Bextra warning and details on the lawsuit, please complete our convenient online contact form.